EPO and anemia: Here we have shown that in the presence of normophosphatemia, dietary phosphorus overload through the actions of FGF23, results in off-target effect of inflammation-induced hypoferremia associated with tissue iron overload, and anemia caused by decreased production and increased destruction of red blood cells that cannot be corrected by increased EPO secretion.